Andere Kunden interessierten sich auch für
![Effect of Mergers on Shareholders Wealth: Evidences From Banking Sector]( "Effect of Mergers on Shareholders Wealth: Evidences From Banking Sector")
Effect of Mergers on Shareholders Wealth: Evidences From Banking Sector51,99 €![Choosing the Right Control System for Organizational Strategies]( "Choosing the Right Control System for Organizational Strategies")
Choosing the Right Control System for Organizational Strategies51,99 €![Complementarity between Client and Vendor IT Capabilities]( "Complementarity between Client and Vendor IT Capabilities")
Complementarity between Client and Vendor IT Capabilities23,99 €![Choosing the Distribution Centre in Logistics Operations]( "Choosing the Distribution Centre in Logistics Operations")
Choosing the Distribution Centre in Logistics Operations36,99 €![INTERACTION OF ADDITIONALITY AND MENTALITY IN ORGANIZATION MANAGEMENT]( "INTERACTION OF ADDITIONALITY AND MENTALITY IN ORGANIZATION MANAGEMENT")
INTERACTION OF ADDITIONALITY AND MENTALITY IN ORGANIZATION MANAGEMENT26,99 €![The Use of Financial Ratios to Predict Acquisition Targets]( "The Use of Financial Ratios to Predict Acquisition Targets")
The Use of Financial Ratios to Predict Acquisition Targets36,99 €![Problems and Solutions in Merger and Acquisition System Integration]( "Problems and Solutions in Merger and Acquisition System Integration")
Problems and Solutions in Merger and Acquisition System Integration26,99 €
Corporate acquisition is a popular way for firms to grow and obtain innovative resources. However, we know little about why acquirers choose one firm over another. We capture the influence of similarity and complementarity between acquirers' and target firms' products (current innovative value) and R&D pipelines (future innovative value) on whether a particular target firm is acquired. Insights from the Pharmaceutical industry reveal that acquirers value similarity and complementarity in target firms differently, based on whether the comparison being made is with respect to their products or their R&D pipelines. Regarding their R&D pipelines, acquirers prefer that the target firm has similar, rather than complementarity, resources. However, the opposite is true concerning their own products: acquirers prefer that the target firm has complementarity, versus similar, resources.